Showing results (1001-1010 of 1,030) with videos related to

Sort By:
Pageof 103
Diabetologia|April 30, 1998
Role of JTT-501, a new insulin sensitiser, in restoring impaired GLUT4 translocation in adipocytes of rats fed a high fat dietJ Terasaki, M Anai, M Funaki, et al.
Leukemia|March 17, 2000
MUM1/IRF4 expression as a frequent event in mature lymphoid malignanciesK Tsuboi, S Iida, H Inagaki, et al.
Molecular Psychiatry|April 24, 2001
Evidence for association of the myo-inositol monophosphatase 2 (IMPA2) gene with schizophrenia in Japanese samplesT Yoshikawa, M Kikuchi, K Saito, et al.
The Journal of Biological Chemistry|March 21, 1997
p85alpha gene generates three isoforms of regulatory subunit for phosphatidylinositol 3-kinase (PI 3-Kinase), p50alpha, p55alpha, and p85alpha, with different PI 3-kinase activity elevating responses to insulinK Inukai, M Funaki, T Ogihara, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|February 21, 2012
Varicella zoster virus meningoencephalitis after allogeneic hematopoietic stem cell transplantationJ Suzuki, M Ashizawa, S Okuda, et al.
Translational Psychiatry|July 1, 2015
Genes associated with the progression of neurofibrillary tangles in Alzheimer's diseaseA Miyashita, H Hatsuta, M Kikuchi, et al.
Diabetologia|May 6, 2004
Oxidative stress induces insulin resistance by activating the nuclear factor-kappa B pathway and disrupting normal subcellular distribution of phosphatidylinositol 3-kinaseT Ogihara, T Asano, H Katagiri, et al.
Acta Pathologica Japonica|September 1, 1979
Some problems on the histopathological diagnosis of non-Hodgkin's malignant lymphoma -- a proposal of a new typeT Suchi, K Tajima, K Nanba, et al.
Endoscopy|September 26, 2001
Low power diode laser treatment using indocyanine green for eradication of esophageal varicesS Hino, H Kakutani, K Ikeda, et al.
International Journal of Immunogenetics|March 9, 2011
Exonic deletion of CASP10 in a patient presenting with systemic juvenile idiopathic arthritis, but not with autoimmune lymphoproliferative syndrome type IIaH Tadaki, H Saitsu, H Kanegane, et al.
Pageof 103